According to Kyodo News on October 17, Modena, a company from the USA, announced on October 17 that they are striving to launch a mixed vaccine for COVID-19 and seasonal influenza in Japan by 2027. CEO Stéphane Bancel mentioned that they are preparing the documents to be submitted to the Japanese Ministry of Health, Labor, and Welfare, hoping to apply within about half a year to a year. The company explained that if the vaccine they are developing can be put into practical use, one dose can provide two types of immunity, potentially reducing the burden on medical institutions and vaccine recipients.